SETDB1 and hepatocellular carcinoma: Accumulating evidences suggest that SETDB1 might function as a novel oncogene to be involved in multiple human cancers, such as hepatocellular carcinoma [6], lung cancer [7], and sporadic cutaneous melanoma [8].